US 9790273
Anti-HLA-B*27 antibodies and uses thereof
granted A61KA61K2039/505A61P
Quick answer
US patent 9790273 (Anti-HLA-B*27 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61P, A61P1/04, A61P19/00